Overcoming resistance to osimertinib in non–small cell lung cancer: Hopes, doubts, and in-between

Antonio Passaro; Umberto Malapelle; Ilaria Attili; Filippo de Marinis

doi:10.1002/cncr.32810

Overcoming resistance to osimertinib in non–small cell lung cancer: Hopes, doubts, and in-between

Antonio Passaro, Umberto Malapelle, Ilaria Attili, Filippo de Marinis

Istituto Europeo di Oncologia

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	2594-2596
Number of pages	3
Journal	Cancer
Volume	126
Issue number	11
DOIs	https://doi.org/10.1002/cncr.32810
Publication status	Published - Jun 1 2020

Keywords

EGFR
lung cancer
NSCLC
osimertinib
resistance

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.32810

Cite this

@article{9063ddb7e623452e857267a9565c74d9,

title = "Overcoming resistance to osimertinib in non–small cell lung cancer: Hopes, doubts, and in-between",

keywords = "EGFR, lung cancer, NSCLC, osimertinib, resistance",

author = "Antonio Passaro and Umberto Malapelle and Ilaria Attili and {de Marinis}, Filippo",

year = "2020",

month = jun,

day = "1",

doi = "10.1002/cncr.32810",

language = "English",

volume = "126",

pages = "2594--2596",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "11",

}

TY - JOUR

T1 - Overcoming resistance to osimertinib in non–small cell lung cancer

T2 - Hopes, doubts, and in-between

AU - Passaro, Antonio

AU - Malapelle, Umberto

AU - Attili, Ilaria

AU - de Marinis, Filippo

PY - 2020/6/1

Y1 - 2020/6/1

KW - EGFR

KW - lung cancer

KW - NSCLC

KW - osimertinib

KW - resistance

UR - http://www.scopus.com/inward/record.url?scp=85081260778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081260778&partnerID=8YFLogxK

U2 - 10.1002/cncr.32810

DO - 10.1002/cncr.32810

M3 - Editorial

C2 - 32154916

AN - SCOPUS:85081260778

VL - 126

SP - 2594

EP - 2596

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 11

ER -

Overcoming resistance to osimertinib in non–small cell lung cancer: Hopes, doubts, and in-between

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this